1. Home
  2. LASR vs PRTC Comparison

LASR vs PRTC Comparison

Compare LASR & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • PRTC
  • Stock Information
  • Founded
  • LASR 2000
  • PRTC 2015
  • Country
  • LASR United States
  • PRTC United States
  • Employees
  • LASR N/A
  • PRTC N/A
  • Industry
  • LASR Semiconductors
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • PRTC Health Care
  • Exchange
  • LASR Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • LASR 412.8M
  • PRTC 439.8M
  • IPO Year
  • LASR 2018
  • PRTC N/A
  • Fundamental
  • Price
  • LASR $17.40
  • PRTC $17.90
  • Analyst Decision
  • LASR Strong Buy
  • PRTC Buy
  • Analyst Count
  • LASR 4
  • PRTC 1
  • Target Price
  • LASR $16.13
  • PRTC $45.00
  • AVG Volume (30 Days)
  • LASR 981.7K
  • PRTC 2.0K
  • Earning Date
  • LASR 07-31-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • LASR N/A
  • PRTC N/A
  • EPS Growth
  • LASR N/A
  • PRTC N/A
  • EPS
  • LASR N/A
  • PRTC 0.21
  • Revenue
  • LASR $205,689,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • LASR $13.20
  • PRTC $35.98
  • Revenue Next Year
  • LASR $8.66
  • PRTC $115.38
  • P/E Ratio
  • LASR N/A
  • PRTC $7.81
  • Revenue Growth
  • LASR 2.66
  • PRTC 44.98
  • 52 Week Low
  • LASR $6.20
  • PRTC $13.30
  • 52 Week High
  • LASR $19.44
  • PRTC $28.39
  • Technical
  • Relative Strength Index (RSI)
  • LASR 62.88
  • PRTC 46.07
  • Support Level
  • LASR $17.45
  • PRTC $19.00
  • Resistance Level
  • LASR $19.44
  • PRTC $19.80
  • Average True Range (ATR)
  • LASR 0.92
  • PRTC 0.33
  • MACD
  • LASR -0.17
  • PRTC -0.12
  • Stochastic Oscillator
  • LASR 53.59
  • PRTC 16.30

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: